# Autologous Serum Obtained by a Closed-Circuit Collection Device

> **NCT07014059** · PHASE2 · NOT_YET_RECRUITING · sponsor: **GIANCARLO FATOBENE** · enrollment: 16 (estimated)

## Conditions studied

- GVHD
- Meibomian Gland Dysfunction (Disorder)
- Stevens-Johnson Syndrome
- Limbal Keratoconjunctivitis
- Recurrent Erosions of Persistent Epithelial Defects
- Neurotrophic Ulcer
- Sjogren Syndrome With Keratoconjunctivitis

## Interventions

- **DRUG:** Autologous Serum 20%

## Key facts

- **NCT ID:** NCT07014059
- **Lead sponsor:** GIANCARLO FATOBENE
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-06-20
- **Primary completion:** 2026-06-20
- **Final completion:** 2027-06-20
- **Target enrollment:** 16 (ESTIMATED)
- **Last updated:** 2025-06-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07014059

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07014059, "Autologous Serum Obtained by a Closed-Circuit Collection Device". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT07014059. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*